Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe/Simvastatin Factorial Study in Hypercholesterolemia
NCT00092664Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2003
- Primary completion
- Sep 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ezetimibe and simvastatin in hypercholesterolemia (4 arms), sponsored by Organon & Co. Primary endpoint: Plasma LDL-C at 14 weeks. Started Jan 2003; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00092664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092664.